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Abstract
Aims/hypothesis The aim of this study was to test the
effectiveness of a screening procedure for depression (SCR)
vs care as usual (CAU) in outpatients with diabetes. The
primary outcome measured was depression score and the
secondary outcomes were mental healthcare consumption,
diabetes-distress and HbA1c.
Materials and methods In a multicentre parallel rando-
mised controlled trial, 223 outpatients with diabetes, who
had an elevated depression score, were randomly assigned
to SCR (n=116) or CAU (n=107), using computer
generated numbers. SCR-patients were invited for a
Composite International Diagnostic Interview (CIDI) to
diagnose depression and/or anxiety (interviewers were not
blinded for group assignment). As part of the intervention,
patients and their physicians were informed of the outcome
of the CIDI in a letter and provided with treatment advice.
At baseline and 6 month follow-up, depression and
diabetes-distress were measured using the Centre for
Epidemiologic Studies Depression Scale (CES-D) and the
Problem Areas in Diabetes survey (PAID). HbA1c levels
were obtained from medical charts.
Results Mean CES-D depression scores decreased from
baseline to 6 months in both groups (24±8 to 21±8 [CAU]
and 26±7 to 22±10 [SCR] respectively [p<0.001]), with
no significant differences between groups. Neither diabetes-
distress nor HbA1c changed significantly within and
between groups. The percentage of patients receiving
mental healthcare increased in the SCR group from 20%
to 28%, compared with 15% to 18% in the CAU group.
Conclusions/interpretation Depression screening with writ-
ten feedback to patient and physician does not improve
depression scores and has a limited impact on mental
healthcare utilisation, compared with CAU. It appears that
more intensive depression management is required to
improve depression outcomes in patients with diabetes.
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Introduction
It has been shown that the prevalence of depression is
relatively high in individuals with type 1 and type 2
diabetes, affecting 12–24% of patients [1, 2]. Depression is
not only associated with impaired quality of life [3], but
also poorer glycaemic control, an increased risk for the
development of diabetes complications and higher mortality
rates [4–6]. Compared with non-diabetic controls, people
with type 2 diabetes also have a 24% increased risk of
developing depression [7]. The reasons for this increased
prevalence and incidence of depression in diabetes are still
poorly understood. The general view is that the burden of
living with diabetes and its complications plays an
important role in the aetiology of depression in diabetes
[8, 9], as well as biochemical changes such as deregulation
of the hypothalamic–pituitary–adrenal axis activities [10]
and low-grade inflammation [11, 12].
Yet, it has been shown that depression in diabetes
patients can be successfully treated by means of cognitive
behavioural therapy, antidepressant medication, or a com-
bination of the two. However, the study on the effectiveness
of cognitive behavioural therapy in diabetes had consider-
able methodological limitations [13]. New intervention
studies in this area are currently being conducted [14–16].
A crucial barrier to effective treatment is that recognition
rates of depression are generally low. For example, in
primary care, physicians failed to recognise depression in
about 30–50% of their depressed patients [17]. In second-
ary care, diabetes nurse specialists failed to recognise and
document high levels of anxiety, depression or diabetes-
specific emotional distress in approximately 75% of cases
who had established high scores on the Hospital Anxiety
and Depression Scale (HADS) or Problem Areas in
Diabetes (PAID) survey [18]. International clinical guide-
lines currently advocate screening for depression in patients
with diabetes [19, 20]. However, the effects of screening
(case-finding) on psychological and diabetes outcomes
have not yet been tested in a randomised controlled study
in patients with diabetes [21]. Results from studies in
patients without diabetes already suggest that screening for
depression per se does not improve outcomes [22, 23]. Yet,
Simon et al. [24] found a two-stage screening process as
part of a stepped care depression treatment programme,
delivered by specialised nurses, to be cost-effective. This
finding would suggest that linking depression screening to
depression treatment is an efficient approach.
The present study aimed to investigate whether active
depression screening, using a stepped, mail-based screening
procedure informing both patient and the treating physician,
results in a significant decrease in depression scores
compared with care as usual (CAU). Secondary outcomes
investigated were: use of mental healthcare services,
diabetes-distress and glycaemic control.
Participants and methods
Setting Data were collected in three tertiary diabetes clinics
from different regions in the Netherlands: the VU Univer-
sity Medical Centre (Amsterdam), Radboud University
Medical Centre (Nijmegen) and Haaglanden Medical
Centre (The Hague). Each clinic serves a patient population
of approximately 2,000 diabetes patients, both type 1 and
type 2. A random sample of a total of 2,055 outpatients was
drawn from the three respective clinics (Amsterdam n=1,000;
(The Hague n=555, Nijmegen n=500)). Baseline data has
been previously described in detail [25, 26].
Procedure At baseline, participants received questionnaire
booklets by mail in two waves: the first assessing socio-
demographics, clinical data and diabetes-specific distress.
The second captured depression and mental healthcare
consumption. We chose to separate the two booklets in
order to avoid over-burdening the respondents. Patients
were invited to return the questionnaires in pre-stamped
envelopes to the research team. Inclusion criteria were: (1)
adult (≥18 years); (2) outpatient with established diabetes
(type 1 or type 2); and (3) elevated depression score (Centre
for Epidemiologic Studies Depression Scale (CES-D) score
of 16 or more). Exclusion criteria were: (1) not being able
to read Dutch; (2) a history of suicide attempt(s); (3) a
history of hospital admission for depression; and (4) a
history of electroconvulsive therapy (ECT) for depression.
After completion of the depression questionnaire, respond-
ents who met inclusion criteria were randomly assigned to:
(1) CAU; or (2) the screening procedure (SCR). We
randomised the participants using computer generated
random numbers by SPSS. Allocation could not be
completely concealed, due to the fact that physicians also
received a copy of the letter regarding the outcome of the
diagnostic psychiatric interview, and thus at least knew
which participants were allocated to the intervention group.
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In the Netherlands, standard outpatient diabetes care
generally consists of, on average, four regular appointments
with an internist and/or diabetes nurse specialist. If needed,
other members of the diabetes team can be consulted, such
as a dietitian, podiatrist, ophthalmologist or medical
psychologist [27]. It is important to emphasise that in the
control group (CAU) the assessment of emotional well-
being was not followed by feedback to patients and/or
healthcare providers. Patients in the SCR group were
invited for a Composite International Diagnostic Interview
(CIDI), using the sections: Mood Disorders and Anxiety
Disorders, allowing for a Diagnostic and Statistical Manual
for Mental Disorders (DSM-IV) diagnosis [28]. In the case
of a diagnosis of a mood disorder and/or an anxiety
disorder, the patient, as well as his/her diabetes specialist
and general practitioner, received a letter with the DSM-IV
diagnosis, and advice regarding treatment options for
depression and/or anxiety. When no mood or anxiety
disorder was detected, the patients also received a letter
with the outcome of the interview and the advice to contact
their physician in case symptoms of depression/anxiety
should worsen, as minor depression is known to be an
important risk factor for the development of major
depression in diabetes [29]. All patients received a brochure
developed by mental health professionals and patients,
supported by the Dutch Psychological Health Foundation
(Fonds Psychische Gezondheid), about depression and its
treatment. This brochure contains seven pages of information
about the symptoms, the potential causes and the prevalence
of depression. It also stresses the importance of seeking
treatment, for example cognitive behavioural therapy or use of
antidepressant medication. Finally, the brochure provides
several useful addresses/phone numbers where patients can
acquire further information and suggestions for self-help
books (see www.psychischegezondheid.nl/dynamic/media/1/
files/depressie.pdf for the brochure [in Dutch].
At the 6 month follow-up, depression and diabetes-
distress were reassessed by means of a mail questionnaire.
Written informed consent was obtained from all participants
and the study was approved by the local medical ethics
advisory committee. The investigations were carried out in
accordance with the principles of the Declaration of
Helsinki as revised in 2000. The present study was not
registered as a clinical trial, as the data collection in the
three clinics took place between 2003 and 2007 and thus
started before the prospective trial registries commenced
(2005).
Demographic and clinical data This first questionnaire
contained questions on: being single/having a partner,
ethnic background (native Dutch, Turkish, Moroccan, or
from Surinam, the Netherlands Antilles, Indonesia, or
other), highest level of completed education, alcohol
consumption and smoking. From the medical records of
the patients, the following data were extracted: age, sex,
type of diabetes, duration of diabetes, microvascular
complications (retinopathy: background or proliferative,
nephropathy and neuropathy), cardiovascular disease, most
recent HbA1c and blood pressure.
Assessment of depression To assess symptoms of depression,
the Dutch version of the CES-D scale was used [30, 31]. This
is a 20-item, self-report scale that asks respondents to
indicate the frequency of occurrence of 20 depressive
symptoms during the previous week. The instrument uses a
four-point response set, ranging from ‘rarely or none of the
time’ to ‘most of the time or always’. Higher scores indicate
more depressive symptoms and a cut-off point of 16 or more
is generally accepted as indicative of a clinically significant
level of depression symptoms [30, 31]. The automated
World Health Organization CIDI-auto is a structured
diagnostic interview, which was used to determine whether
the patients suffered from a depressive disorder and/or an
anxiety disorder, according to DSM-IV criteria [28, 32, 33].
The main advantage of the CIDI-auto is that the questions
are fully specified. In our study, lay interviewers, mostly
medical or psychology masters students, were trained by a
certified CIDI interviewer (FP) to use the CIDI-auto. These
interviewers were not blinded to group assignment.
Assessment of diabetes-specific emotional distress Diabetes-
specific emotional distress was assessed using the Dutch
version of the PAID survey [34, 35]. This questionnaire
consists of 20 items, which can be rated on a five-point
Likert scale ranging from 0 (no problem) to 4 (serious
problem). Examples of items are: ‘Not accepting diabetes’,
‘Worrying about the future and the possibility of serious
complications’, ‘Feeling overwhelmed by your diabetes
regimen’ or ‘Feeling alone with diabetes’. Following the
recommendation of the measure’s authors, the PAID
questionnaire scores are transformed to a scale of 0–100,
higher scores indicating more serious emotional problems.
Statistical analyses Statistical analyses were performed
using SPSS version 16.0 (SPSS Inc., Chicago, IL, USA).
The primary outcome variable was depression score;
diabetes-distress, mental healthcare use and HbA1c were
regarded as secondary outcomes. The present study has
sufficient power to detect a medium effect size of f=0.25.
For example, the correlation between two time measures of
CES-D depression score was assumed to be moderately
large r(m1, m2) = 0.50. Moreover, with a population
standard deviation of the CES-D (each group) equalling 8,
the present study was able to detect a difference of four
points in CES-D change scores between the two treatment
groups with a power of 0.93. The CES-D depression scores
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can range from 0 to 60 as, for each of the 20 items, the
scores range from 0 to 3.
Continuous demographic data for the participants were
analysed using independent means t tests, and χ2 tests were
used for categorical variables. A p value <0.05 was
considered to be statistically significant. Data were ana-
lysed according to the intention-to-treat principle with the
baseline value carried forward in cases of missing follow-
up data. First, by means of t tests and χ2 tests, baseline
variables were compared between the intervention and
CAU group. Then, general linear model repeated measures
were conducted with the CES-D as dependent variable,
with two independent variables: time (within-participant)
and group (between-participant). The same analysis was
performed with the PAID scores or HbA1c as dependent
variable.
Results
A total of 80 patients declined to participate, and 1,043 did
not respond (Fig. 1), leaving 932 patients who returned the
first questionnaire; 730 returned the second (depression)
questionnaire. A history of suicide attempts was reason to
exclude 58 patients, and another 507 patients were
excluded because they had a CES-D depression score
below 16. Six patients were excluded because they had
received more than one inpatient treatment for depression.
In total, 223 patients met inclusion criteria: 107 were
randomly assigned to the CAU group and 116 to the SCR
group, which included the CIDI with written feedback
regarding the outcome of the interview (Fig. 1).
At baseline, the mean age of the 223 participants was
54 years, and almost 60% were women. Mean HbA1c was
8.0% in both groups, mean BMI was 29 and 33–40% of the
participants had type 1 diabetes. Of the patients with type 2
diabetes, 48–53% were treated with insulin. The majority of
patients had a Europid ethnic background. A minority of
respondents had a Surinamese (6–7%) or Turkish ethnic
background (3–5%). Mean duration of diabetes (type 1 and
type 2 taken together) was 17 years in both groups. At
baseline, about a quarter of the patients had nephropathy,
cardiovascular disease and/or background retinopathy.
Neuropathy was present in 26–35% of the patients. Socio-
demographic and clinical variables did not differ signifi-
cantly between the intervention and the control group
2,055 randomly selected  
diabetes outpatients invited
932 screened for exclusion 
criteria 
730 screened for depression
80 refused 
1,043 did not respond 
58 history of suicide attempt 
6  more than one inpatient depression treatment 
21 language problems 
23 refused second questionnaire 
13 moved to another hospital 
81 did not respond to second questionnaire  
223 eligible patients with a 
CES-D  score >15 signed 
informed consent 
223 eligible patients 
enrolled 
6 month follow-up 
46 non-response 
70 complete survey (60%) 
6 month follow-up 
32 non-response 
75 complete survey (70%) 
507 excluded with CES-D score <16 
97 completed CIDI 
116 CAU + invitation for a CIDI 107 CAU  
Fig. 1 Screening for depression
in outpatients with diabetes
study: patient enrolment
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(Table 1). Patients in the CAU group more often reported low
education (43% vs 31% in the intervention group, NS). In an
additional analysis we compared baseline characteristics of
those who were lost to follow-up with those who completed
the study and found the drop outs had higher baseline
depression scores than completers (27±8 vs 24±7,
p<0.003), more often had low education (46% vs 32%,
p=0.03) and more often had a non-Dutch ethnic background
(25% vs 9%, p=0.002). The groups did not differ regarding
age, BMI, type of diabetes or baseline HbA1c.
Prevalence of mood and anxiety disorders in the interven-
tion group Data on the prevalence of mood and anxiety
disorders in the intervention group, based on the results of
the CIDI interviews, have been published elsewhere [23].
In brief, 8% of the patients with type 1 diabetes were
diagnosed with a depressive disorder (no sex difference),
compared with 2% of men and 21% of women with type 2
diabetes. In the present study, 116 patients with a high
CES-D score were invited for a CIDI interview: 13 refused
to be interviewed and 6 could not be contacted. Thus 97
patients underwent the psychiatric diagnostic interview. In
the intervention group, 54% (52/97) of those invited
suffered subthreshold depression (no mood or anxiety
disorder diagnosed). Thirty-two patients were diagnosed
with a mood disorder (33%), 14 patients with generalised
anxiety disorder (15%), one with blood/injection phobia
(1%), six patients with natural/environment phobia (6%),
15 with social phobia (16%), 3 with panic disorder (3%)
and five patients with agoraphobia (5%). Twenty-eight
patients (30%) were diagnosed with two or more mood/
anxiety disorders.
SCR CAU p value
n 116 107
Demographics
Age (years) 55±12 52±16 0.150
No partner (%) 32 (37/116) 28 (30/107) 0.561
Low education (%) 43 (50/116) 31 (33/107) 0.072
Female sex (%) 58 (67/116) 58 (62/107) 0.978
Ethnicity
Dutch (%) 87 (94/108) 81 (81/100) 0.734
Moroccan (%) 2 (2/108) 1 (1/100)
Turkish (%) 3 (3/108) 5 (5/100)
Surinami (%) 7 (7/108) 6 (6/100)
Other (%) 1 (3/108) 6 (6/100)
Hospital
VUmc, Amsterdam (%) 48 (56/116) 47 (50/107) 0.967
Westeinde, The Hague (%) 28 (32/116) 29 (31/107)
St Radboud, Nijmegen (%) 24 (28/116) 24 (26/107)
Clinical values
HbA1c (%) 8.0±1.4 8.0±1.5 0.669
BMI 29±7 29±8 0.787
SBP (mmHg) 138±16 136±18 0.508
DBP (mmHg) 77±10 76±10 0.498
Type 1 diabetes (%) 33 (38/116) 40 (43/107) 0.515
Type 2 diabetes (diet/oral hypoglycaemic agents) (%) 14 (16/116) 12 (13/107)
Type 2 diabetes treated with insulin (%) 53 (62/116) 48 (51/107)
Nephropathy (%) 20 (20/102) 30 (29/97) 0.092
Background retinopathy (%) 28 (29/103) 20 (19/95)
Proliferative retinopathy (%) 5 (5/103) 7 (7/95) 0.350
Neuropathy (%) 35 (35/101) 26 (25/96) 0.189
Any microvascular disease (%) 65 (67/103) 51 (49/97) 0.033
Cardiovascular disease (%) 26 (26/100) 25 (25/93) 0.890
Duration of diabetes (years) 17±11 17±11 0.954
CES-D depression score 26±7 24±7 0.199
Table 1 Baseline demographic
and clinical characteristics of
intervention and CAU patients
SBP, systolic blood pressure;
DBP, diastolic blood pressure
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Effects of the screening intervention on mental healthcare
consumption The percentage of patients at baseline report-
ing to have received (any) psychological treatment in the
past did not differ between the two groups (41% [42/103] in
the CAU group vs 44% [50/114] in the SCR group,
p=0.14). At baseline, the percentages of patients that
reported being under treatment for depression did not differ
significantly (15% in the CAU and 20% in the SCR group).
The percentage of patients that reported to have received
depression treatment during the study period did not differ
significantly between the groups (18% in the CAU and
28% in the SCR group).
Effects of the screening intervention on depression score,
diabetes-distress and HbA1c Follow-up data was complete
for 145 of 223 patients (65%). At the 6 month follow-up,
depression scores had significantly improved in both
depressed groups (p<0.001), but the improvement did not
differ between groups (21±8 [CAU] vs 22±10 [SCR], NS).
Although mean CES-D scores had decreased after 6 months,
the percentage of patients with elevated depression scores
(CES-D ≥ 16) was still relatively high and did not differ
between groups (68% [CAU] vs 75% [SCR], NS).
General linear model repeated measures analysis con-
firmed that the screening intervention did not affect CES-D
depression scores nor the level of diabetes-specific emo-
tional distress. In the analysis using CES-D, there was a
significant time effect (p<0.001), with both groups show-
ing a decrease in depression scores, but no significant group
effect over time. Intention-to-treat analysis with the baseline
value carried forward in the case of missing follow-up data,
confirmed the absence of effects of the screening interven-
tion on depression scores or levels of diabetes-specific
distress, or HbA1c (data not shown).
Discussion
The main finding of the present study is that a mail-based
screening procedure for depression in outpatients with
diabetes did not have a substantial impact on the number
of patients seeking mental healthcare. This could explain
why the screening procedure did not yield better outcomes
compared with CAU with respect to CES-D depression
scores, diabetes-distress or HbA1c. Importantly, levels of
depression, anxiety and diabetes-specific distress remained
relatively high in both groups.
The results of the present study are in line with earlier
studies that have been carried out in primary care settings,
showing that disclosure of depression status in itself, based
on case-finding instruments, does not impact depression
scores [21, 36–38]. Apparently, detection of depression
does not automatically prompt physicians or patients to
seek mental healthcare. In our study, letters were sent to the
depressed patients and their treating physicians. Although
this intervention included advice to seek treatment for
depression, this was not tied to a specific treatment
programme nor was there any follow-up to check if action
had been taken. Simon et al. [24] have shown that linking
the screening outcome to treatment does help to achieve
better depression outcomes. Indeed, in an earlier trial
testing the effects of individual monitoring and discussing
emotional well-being as part of the periodic diabetes
consultation in secondary care by diabetes nurse specialists,
we found significant improvements in emotional well-being
compared with CAU [39]. We should, therefore, not only
screen for depression in diabetes care, as advocated by the
ADA and IDF [19, 20], but ensure that the depression
screening outcome is combined with an appropriate
depression treatment programme [21, 40].
Strengths of our study include its multicentre rando-
mised controlled design, the use of a diagnostic interview
schedule that allows diagnosis of depressive disorder and
the relatively large sample size. The present study has
sufficient power to detect a medium effect size of f=0.25.
On the other hand, response was rather low and selection
bias during the inclusion phase and selective loss to follow-
up might have influenced the results. As depressed patients
often lack energy and optimism, it may be that a relatively
large number of the depressed patients did not return the
questionnaire at baseline. In addition, later in the study, a
considerable number of male participants with type 2
diabetes refused the psychiatric diagnostic interview. In
our study, loss to follow-up was particularly associated with
a high baseline depression score, a low level of education
and non-Dutch descent. Attrition bias may have led to
underestimation of the effect. However, unfortunately, it is
not possible to check this assumption.
Overall, the percentage of male participants is lower than
would be expected. Particularly, male participants with a
non-Dutch background seem to be under-represented. This
may have influenced our results. However, the screening
procedure appeared to be feasible and generally acceptable
to patients, with only a few refusals.
Moreover, we compared CAU (with no diagnostic
interview) with a complex intervention consisting of several
steps: (1) assessment of depression using a self-report
questionnaire; (2) a diagnostic psychiatric interview in case
of a high depression score; (3) feedback regarding the
outcome of the diagnostic interview to patient, internist and
primary care physician; and (4) brochure on depression. An
inevitable limitation of our design is that we were not able
to determine the exact impact of each separate step, such as
the diagnostic interview.
The question arises as to the clinical implications of our
findings. It would seem appropriate to revisit the recom-
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mendations of the ADA, IDF and other diabetes organ-
isations to screen for depression, and stress the importance
of linking screening to treatment. For this purpose, mental
health services for diabetes patients need to be in place.
Unfortunately, psychological services for diabetes patients
are still lacking or scarce in most settings [41, 42]. This
calls for improving access to mental health services in
diabetes as well as developing new therapeutic strategies
that can enlarge reach at relatively low costs, for example
by offering web-based programmes [14].
In summary, our study shows that a mail-based screening
procedure for depression in outpatients with diabetes only
marginally affects uptake of mental healthcare, thereby
failing to improve depression scores, levels of diabetes-
specific emotional stress or glycaemic control. It is
imperative that screening for depression is embedded in a
comprehensive depression treatment programme.
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